These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3340633)
1. Recent aspects of diagnosis and treatment of lipoprotein disorders. Impact on prevention of atherosclerotic diseases. Proceedings of an international symposium. Vienna, August 21-23, 1986. Prog Clin Biol Res; 1988; 255():1-383. PubMed ID: 3340633 [No Abstract] [Full Text] [Related]
2. Detection of lipoprotein abnormalities by a sensitive electrophoretic test system for the prevention of cardiovascular disease. Papadopoulos NM Int Angiol; 1985; 4(2):249-53. PubMed ID: 3831146 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis and treatment of lipoprotein disorders. Stacpoole P Compr Ther; 1989 Apr; 15(4):28-44. PubMed ID: 2650981 [No Abstract] [Full Text] [Related]
5. [Hyperlipoproteinemia: epidemiology, pathogenesis, clinical symptoms, significance for the pathogenesis of arteriosclerosis]. Haller H Z Arztl Fortbild (Jena); 1980 Jul; 74(13-14):640-5. PubMed ID: 7434801 [No Abstract] [Full Text] [Related]
6. Rational drug therapy of the hyperlipoproteinemias, Part I. Blum CB; Levy RI Ration Drug Ther; 1986 Sep; 20(9):1-7. PubMed ID: 3575746 [No Abstract] [Full Text] [Related]
7. [Update on dyslipoproteinemias and their role in changes in the statoacoustic apparatus]. Pallestrini EA; Borasi F Ann Laringol Otol Rinol Faringol; 1978; 76(3):239-76. PubMed ID: 233339 [No Abstract] [Full Text] [Related]
9. Detection and treatment of lipid and lipoprotein disorders of childhood. Proceedings of the Third International Atherosclerosis Conference. Vienna, Austria, April 4-9, 1983. Prog Clin Biol Res; 1985; 188():1-229. PubMed ID: 4059252 [No Abstract] [Full Text] [Related]
10. Lipoprotein metabolism and atherogenesis: implications for therapy. Kostner GM Cardiology; 1991; 78(3):194-201. PubMed ID: 1651161 [TBL] [Abstract][Full Text] [Related]
11. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424 [TBL] [Abstract][Full Text] [Related]
12. [Methodological aspects of the etiology and pathogenesis of atherosclerosis]. Klimov AN; Nagornev VA Kardiologiia; 1983 Mar; 23(3):5-10. PubMed ID: 6855062 [No Abstract] [Full Text] [Related]
13. Lipoprotein disorders as related to atherosclerotic cardiovascular disease. Scanu AM Surg Clin North Am; 1995 Aug; 75(4):557-67. PubMed ID: 7638704 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis, clinical features and treatment of hyperlipidemias in children]. Widhalm K Monatsschr Kinderheilkd; 1982 Oct; 130(10):747-52. PubMed ID: 7177116 [TBL] [Abstract][Full Text] [Related]